Rayonier (RYN) Competitors $26.42 +0.27 (+1.03%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends RYN vs. OHI, CUBE, RHP, HR, SBRA, GEO, EPR, PCH, NHI, and SHOShould you be buying Rayonier stock or one of its competitors? The main competitors of Rayonier include Omega Healthcare Investors (OHI), CubeSmart (CUBE), Ryman Hospitality Properties (RHP), Healthcare Realty Trust (HR), Sabra Health Care REIT (SBRA), The GEO Group (GEO), EPR Properties (EPR), PotlatchDeltic (PCH), National Health Investors (NHI), and Sunstone Hotel Investors (SHO). These companies are all part of the "specialized reits" industry. Rayonier vs. Omega Healthcare Investors CubeSmart Ryman Hospitality Properties Healthcare Realty Trust Sabra Health Care REIT The GEO Group EPR Properties PotlatchDeltic National Health Investors Sunstone Hotel Investors Omega Healthcare Investors (NYSE:OHI) and Rayonier (NYSE:RYN) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, community ranking, earnings, profitability, dividends, media sentiment and analyst recommendations. Do insiders & institutionals hold more shares of OHI or RYN? 65.3% of Omega Healthcare Investors shares are held by institutional investors. Comparatively, 89.1% of Rayonier shares are held by institutional investors. 1.4% of Omega Healthcare Investors shares are held by insiders. Comparatively, 0.8% of Rayonier shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is OHI or RYN a better dividend stock? Omega Healthcare Investors pays an annual dividend of $2.68 per share and has a dividend yield of 7.1%. Rayonier pays an annual dividend of $1.14 per share and has a dividend yield of 4.3%. Omega Healthcare Investors pays out 197.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Rayonier pays out 107.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Do analysts prefer OHI or RYN? Omega Healthcare Investors currently has a consensus target price of $40.18, indicating a potential upside of 6.22%. Rayonier has a consensus target price of $33.00, indicating a potential upside of 24.91%. Given Rayonier's higher possible upside, analysts plainly believe Rayonier is more favorable than Omega Healthcare Investors.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Omega Healthcare Investors 0 Sell rating(s) 6 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50Rayonier 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community believe in OHI or RYN? Omega Healthcare Investors received 144 more outperform votes than Rayonier when rated by MarketBeat users. Likewise, 57.87% of users gave Omega Healthcare Investors an outperform vote while only 54.53% of users gave Rayonier an outperform vote. CompanyUnderperformOutperformOmega Healthcare InvestorsOutperform Votes44557.87% Underperform Votes32442.13% RayonierOutperform Votes30154.53% Underperform Votes25145.47% Is OHI or RYN more profitable? Omega Healthcare Investors has a net margin of 34.41% compared to Rayonier's net margin of 15.84%. Omega Healthcare Investors' return on equity of 8.83% beat Rayonier's return on equity.Company Net Margins Return on Equity Return on Assets Omega Healthcare Investors34.41% 8.83% 3.81% Rayonier 15.84%2.95%1.52% Which has more risk and volatility, OHI or RYN? Omega Healthcare Investors has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Comparatively, Rayonier has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Does the media favor OHI or RYN? In the previous week, Rayonier had 2 more articles in the media than Omega Healthcare Investors. MarketBeat recorded 7 mentions for Rayonier and 5 mentions for Omega Healthcare Investors. Omega Healthcare Investors' average media sentiment score of 1.17 beat Rayonier's score of 0.80 indicating that Omega Healthcare Investors is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omega Healthcare Investors 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rayonier 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, OHI or RYN? Omega Healthcare Investors has higher revenue and earnings than Rayonier. Rayonier is trading at a lower price-to-earnings ratio than Omega Healthcare Investors, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmega Healthcare Investors$1.01B10.10$242.18M$1.3627.82Rayonier$1.00B3.92$173.49M$1.0624.92 SummaryOmega Healthcare Investors beats Rayonier on 15 of the 20 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Rayonier News Delivered to You Automatically Sign up to receive the latest news and ratings for RYN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RYN vs. The Competition Export to ExcelMetricRayonierReal estate investment trusts IndustryConstruction SectorNYSE ExchangeMarket Cap$3.94B$6.96B$8.74B$19.18BDividend Yield3.99%6.79%1.87%3.58%P/E Ratio24.9242.5327.6641.22Price / Sales3.927.822.2717.58Price / Cash20.1917.7922.2221.28Price / Book2.092.546.185.32Net Income$173.49M$146.30M$516.58M$989.67M7 Day Performance-8.36%-3.82%-4.46%-3.45%1 Month Performance-12.75%-4.28%-4.94%-3.73%1 Year Performance-19.33%1.86%36.24%12.06% Rayonier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RYNRayonier4.0028 of 5 stars$26.42+1.0%$33.00+24.9%-18.8%$3.94B$1.00B24.92420Ex-DividendHigh Trading VolumeOHIOmega Healthcare Investors4.3784 of 5 stars$39.44+0.6%$40.18+1.9%+23.0%$10.65B$949.74M28.8950Positive NewsCUBECubeSmart3.6574 of 5 stars$46.53+0.6%$51.36+10.4%-5.4%$10.52B$1.05B26.143,040Dividend IncreaseRHPRyman Hospitality Properties3.9929 of 5 stars$111.61-1.4%$128.57+15.2%-1.4%$6.69B$2.32B20.111,471HRHealthcare Realty Trust3.0077 of 5 stars$17.48+1.5%$17.17-1.8%-1.4%$6.19B$1.29B-11.01580Analyst DowngradeInsider TradeNews CoveragePositive NewsSBRASabra Health Care REIT1.777 of 5 stars$17.53+0.2%$19.14+9.2%+18.5%$4.15B$647.51M42.6840Positive NewsGEOThe GEO Group2.2262 of 5 stars$28.00+2.2%$33.50+19.6%+159.0%$3.92B$2.41B94.5216,400Analyst ForecastPositive NewsEPREPR Properties3.7325 of 5 stars$45.31+0.4%$48.28+6.5%-8.9%$3.43B$636.87M19.5060PCHPotlatchDeltic4.3541 of 5 stars$42.52+0.6%$49.25+15.8%-21.2%$3.35B$1.02B203.381,384Positive NewsNHINational Health Investors3.4438 of 5 stars$72.750.0%$76.33+4.9%+22.6%$3.30B$319.83M25.0020Positive NewsSHOSunstone Hotel Investors2.4361 of 5 stars$12.36+1.2%$12.20-1.3%+11.7%$2.48B$986.48M16.0740Positive News Related Companies and Tools Related Companies OHI Alternatives CUBE Alternatives RHP Alternatives HR Alternatives SBRA Alternatives GEO Alternatives EPR Alternatives PCH Alternatives NHI Alternatives SHO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:RYN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rayonier Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rayonier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.